Showing results (61-70 of 170) with videos related to
Sort By:
Pageof 17
Biomed Research International|December 13, 2019
miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1Markus Krebs, Christoph Behrmann, Charis Kalogirou, et al.Journal of Clinical Medicine|March 6, 2020
miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In VitroMarkus Krebs, Antonio Giovanni Solimando, Charis Kalogirou, et al.Journal of Pharmaceutical and Biomedical Analysis|February 5, 2022
Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratioSebastian Zimmermann, Fatemeh Aghai, Bastian Schilling, et al.Cancer Medicine|June 18, 2014
Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort studyElisabeth Livingstone, Loes M Hollestein, Myrthe P P van Herk-Sukel, et al.Journal for Immunotherapy of Cancer|September 24, 2025
Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitisKim Nikola Oliva, Lisa Arnold, Lucie Heinzerling, et al.European Journal of Cancer (Oxford, England : 1990)|June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanomaSophia Kreft, Anja Gesierich, Thomas Eigentler, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cellsBenjamin Weide, Alexander Martens, Henning Zelba, et al.European Journal of Cancer (Oxford, England : 1990)|March 11, 2019
A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification taskTitus J Brinker, Achim Hekler, Alexander H Enk, et al.The American Journal of Surgical Pathology|October 9, 2015
Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic MarkerAbbas Agaimy, Katja Specht, Robert Stoehr, et al.Journal of Pharmaceutical and Biomedical Analysis|February 25, 2023
Clinical validation and assessment of feasibility of volumetric absorptive microsampling (VAMS) for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib, and ruxolitinibSebastian Zimmermann, Fatemeh Aghai-Trommeschlaeger, Sabrina Kraus, et al.Pageof 17